BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim MW, Lee G, Niidome T, Komohara Y, Lee R, Park YI. Platelet-Like Gold Nanostars for Cancer Therapy: The Ability to Treat Cancer and Evade Immune Reactions. Front Bioeng Biotechnol 2020;8:133. [PMID: 32158752 DOI: 10.3389/fbioe.2020.00133] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Alimardani V, Rahiminezhad Z, DehghanKhold M, Farahavar G, Jafari M, Abedi M, Moradi L, Niroumand U, Ashfaq M, Abolmaali SS, Yousefi G. Nanotechnology-based cell-mediated delivery systems for cancer therapy and diagnosis. Drug Deliv Transl Res 2022. [PMID: 36074253 DOI: 10.1007/s13346-022-01211-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bagasariya D, Charankumar K, Shah S, Famta P, Khatri D, Singh Raghuvanshi R, Bala Singh S, Srivastava S. Biomimetic Nanotherapeutics: Employing Nanoghosts to fight Melanoma. Eur J Pharm Biopharm 2022:S0939-6411(22)00137-0. [PMID: 35787429 DOI: 10.1016/j.ejpb.2022.06.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xiao G, Zhang Z, Chen Q, Wu T, Shi W, Gan L, Liu X, Huang Y, Lv M, Zhao Y, Wu P, Zhong L, He J. Platelets for cancer treatment and drug delivery. Clin Transl Oncol 2022;24:1231-7. [PMID: 35218523 DOI: 10.1007/s12094-021-02771-x] [Reference Citation Analysis]
4 K. Tapasya KT, Kumar AS, Dharmarajan A, Parvathi VD. Nanocarriers: The Promising Future to Cancer Diagnostics and Treatment. Biomed Pharmacol J 2022;15:785-802. [DOI: 10.13005/bpj/2416] [Reference Citation Analysis]
5 Yang R, Gao Y, Ouyang Z, Shi X, Shen M. Gold nanostar‐based complexes applied for cancer theranostics. VIEW 2022;3:20200171. [DOI: 10.1002/viw.20200171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Khafaji M, Bavi O, Zamani M. Gold-based hybrid nanostructures: more than just a pretty face for combinational cancer therapy. Biophys Rev. [DOI: 10.1007/s12551-021-00926-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Han H, Bártolo R, Li J, Shahbazi M, Santos HA. Biomimetic platelet membrane-coated nanoparticles for targeted therapy. European Journal of Pharmaceutics and Biopharmaceutics 2022;172:1-15. [DOI: 10.1016/j.ejpb.2022.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
8 Huang C, Guan X, Lin H, Liang L, Miao Y, Wu Y, Bao H, Wu X, Shen A, Wei M, Huang J. Efficient Photoacoustic Imaging With Biomimetic Mesoporous Silica-Based Nanoparticles. Front Bioeng Biotechnol 2021;9:762956. [PMID: 34917596 DOI: 10.3389/fbioe.2021.762956] [Reference Citation Analysis]
9 Qindeel M, Sabir F, Sargazi S, Mohammadzadeh V, Mulla SI. New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases. J Nanopart Res 2021;23. [DOI: 10.1007/s11051-021-05370-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Battaglia L, Scomparin A, Dianzani C, Milla P, Muntoni E, Arpicco S, Cavalli R. Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape. Pharmaceutics 2021;13:1617. [PMID: 34683910 DOI: 10.3390/pharmaceutics13101617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Zhao Y, Li A, Jiang L, Gu Y, Liu J. Hybrid Membrane-Coated Biomimetic Nanoparticles (HM@BNPs): A Multifunctional Nanomaterial for Biomedical Applications. Biomacromolecules 2021;22:3149-67. [PMID: 34225451 DOI: 10.1021/acs.biomac.1c00440] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
12 Li A, Zhao Y, Li Y, Jiang L, Gu Y, Liu J. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles. Drug Deliv 2021;28:1237-55. [PMID: 34142930 DOI: 10.1080/10717544.2021.1938757] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 20.0] [Reference Citation Analysis]
13 Hussain Z, Rahim MA, Jan N, Shah H, Rawas-Qalaji M, Khan S, Sohail M, Thu HE, Ramli NA, Sarfraz RM, Abourehab MAS. Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy. J Control Release 2021;335:130-57. [PMID: 34015400 DOI: 10.1016/j.jconrel.2021.05.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 25.0] [Reference Citation Analysis]
14 Chen X, Liu B, Tong R, Zhan L, Yin X, Luo X, Huang Y, Zhang J, He W, Wang Y. Orchestration of biomimetic membrane coating and nanotherapeutics in personalized anticancer therapy. Biomater Sci 2021;9:590-625. [PMID: 33305765 DOI: 10.1039/d0bm01617a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
15 Kunde SS, Wairkar S. Platelet membrane camouflaged nanoparticles: Biomimetic architecture for targeted therapy. Int J Pharm 2021;598:120395. [PMID: 33639226 DOI: 10.1016/j.ijpharm.2021.120395] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 20.0] [Reference Citation Analysis]
16 Rai A, Noor S, Ahmad SI, Alajmi MF, Hussain A, Abbas H, Hasan GM. Recent Advances and Implication of Bioengineered Nanomaterials in Cancer Theranostics. Medicina (Kaunas) 2021;57:91. [PMID: 33494239 DOI: 10.3390/medicina57020091] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
17 陈 超. Advances in Reformed Erythrocytes as Drug Deliver System. NAT 2021;11:36-42. [DOI: 10.12677/nat.2021.113005] [Reference Citation Analysis]
18 Dash P, Piras AM, Dash M. Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy. Journal of Controlled Release 2020;327:546-70. [DOI: 10.1016/j.jconrel.2020.09.012] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 28.5] [Reference Citation Analysis]
19 Arasi MB, Pedini F, Valentini S, Felli N, Felicetti F. Advances in Natural or Synthetic Nanoparticles for Metastatic Melanoma Therapy and Diagnosis. Cancers (Basel) 2020;12:E2893. [PMID: 33050185 DOI: 10.3390/cancers12102893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
20 Guido C, Maiorano G, Cortese B, D'Amone S, Palamà IE. Biomimetic Nanocarriers for Cancer Target Therapy. Bioengineering (Basel) 2020;7:E111. [PMID: 32937963 DOI: 10.3390/bioengineering7030111] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
21 Chillà A, Margheri F, Biagioni A, Del Rosso T, Fibbi G, Del Rosso M, Laurenzana A. Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma. Cancers (Basel) 2020;12:E1771. [PMID: 32630815 DOI: 10.3390/cancers12071771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Siddique S, Chow JCL. Gold Nanoparticles for Drug Delivery and Cancer Therapy. Applied Sciences 2020;10:3824. [DOI: 10.3390/app10113824] [Cited by in Crossref: 107] [Cited by in F6Publishing: 114] [Article Influence: 53.5] [Reference Citation Analysis]
23 Karadağ A, Aydın A, Tekin Ş, Akbaş H, Şahin O, Sen F. Synthesis, characterization and anticancer activity in vitro evaluation of novel dicyanoaurate (I)-based complexes. Life Sci 2020;251:117635. [PMID: 32272179 DOI: 10.1016/j.lfs.2020.117635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Li Y, Gan Y, Li C, Yang YY, Yuan P, Ding X. Cell membrane-engineered hybrid soft nanocomposites for biomedical applications. J Mater Chem B 2020;8:5578-96. [DOI: 10.1039/d0tb00472c] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]